The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...
J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...
J&J said that about a third of adults will not respond to oral antidepressants alone. Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team.
Early logos for 2JJ, or Double Jay as it was known, before it became triple j in the early 1980s. Double J celebrates the 50th anniversary of triple j on January 19 with a special 12 hour ...
Satya (22). All of them belong to Vaniyambadi town. Initial inquiry revealed that the deceased teenager J. Narasimhan (16) was a friend for arrested persons. They studied in the schools in the ...
Revvity's 2025 Guidance Signals Cautious Optimism Amid Slower-Than-Expected Pharma Spending Recovery
After significant business transformation activities in recent years, Revvity (formerly PerkinElmer) has been in a constant state of evolution since 2016 when the company made the transition into ...
KeyBanc analyst Paul Knight maintained a Buy rating on Revvity (RVTY – Research Report) today and set a price target of $145.00. The company’s shares closed last Friday at $126.13. Leverage ...
KeyBanc raised the firm’s price target on Revvity (RVTY) to $145 from $132 and keeps an Overweight rating on the shares. The firm notes that having pre-announced Q4 in mid-January, all eyes were ...
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year ...
For decades, J.D. Power’s research has been a key tool for savvy consumers trying to separate companies with high-quality products and world-class customer service from the other guys.
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AIâ„¢ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging ...
Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI ™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results